Mirada Medical, an advanced oncology imaging developer, announced that it will be launching Casemeeting, a new product designed to improve image presentation at tumor board meetings, at the 2010 RSNA conference in Chicago.
The tumor board meeting has become a key instrument for sites seeking to personalize best practice to individual patients. Mirada Casemeeting will significantly reduce the burden of tumor board preparation for radiologists without compromising on the quality of the information presented. Using Casemeeting, radiologists will be able to send key images, findings and full volumetric data directly from the reading workstation to tumor board. The system will then automatically generate a presentation for each patient.
During the tumor board, Casemeeting users will be able to simply select the patient and present all of the key information without the need for additional preparation time, data transfer, or setup. Importantly, at any time during the meeting, the presenter is only a single click away from a synchronized, fully featured 3D view of all the case images, including tools for multi-planar reconstructed views, fusion for PET/CT and MR-PET, multi-timepoint for response assessment, and quantification tools. In addition, text, image, or attachment slides can also be added by other meeting attendees including medical oncologists, pathologists, radiation oncologists, surgeons, and the meeting chair.
Casemeeting is the third offering in Mirada’s suite of oncology imaging products which together support the sharing and communication of advanced diagnostic findings and quantifications among all clinicians responsible for a patient’s management. The Casemeeting software is complementary to XD3, Mirada’s advanced diagnostic imaging review software, and Caseaccess, which gives the referrer Web-based access of data and findings available. Casemeeting will be launched globally by Mirada Medical in early 2011 and the program will be available for demonstration in Mirada Medical’s booth at RSNA. Mirada Medical will showcase all of its latest industry leading developments in Booth 7520, Hall B, North Building of McCormick Place.
“A prerequisite to personalized medicine is effective inter-disciplinary communication and discussion of pertinent clinical information for the specific case under review. Our aim is to allow the highest quality of diagnostic imaging information to be available to all of the specialists who typically work together with the patient to treat cancer cases. The introduction of Casemeeting now means that a complete set of images and findings can be quickly prepared for the tumor board meeting, and presented with the ability to review the case in advanced visualization software should the need arise,” said Hugh Bettesworth, Mirada Medical CEO.